Literature DB >> 22038375

Case-control study of the relationship of functioning to suicide in a community-based sample of individuals with schizophrenia in China.

John Kasckow1, Nancy Liu, Michael R Phillips.   

Abstract

Suicide is a leading cause of premature death among people with schizophrenia. Some studies indicate that increased difficulties in functioning are associated with suicidality in persons with schizophrenia. We conducted a secondary analysis of 74 suicides (cases) and 24 accidental deaths (controls) among persons with schizophrenia identified in a national psychological autopsy study in China. Between cases and controls, we compared the effect of schizophrenia on work, daily activities, emotions, social relationships and self-care at the time the illness was most severe. There was no difference in the overall maximum dysfunction associated with the illness between groups. None of the 5 measures (work, activities, emotions, relationships, self-care) were different between the two groups. This study of individuals with DSM-IV schizophrenia who died by suicide in a non-western culture only partially supports findings from clinical studies in western cultures.

Entities:  

Mesh:

Year:  2011        PMID: 22038375      PMCID: PMC3321264          DOI: 10.1007/s10597-011-9460-3

Source DB:  PubMed          Journal:  Community Ment Health J        ISSN: 0010-3853


  10 in total

1.  Risk factors for suicide in China: a national case-control psychological autopsy study.

Authors:  Michael R Phillips; Gonghuan Yang; Yanping Zhang; Lijun Wang; Huiyu Ji; Maigeng Zhou
Journal:  Lancet       Date:  2002-11-30       Impact factor: 79.321

Review 2.  Suicide among patients with schizophrenia: a consideration of risk and protective factors.

Authors:  Lori P Montross; Sidney Zisook; John Kasckow
Journal:  Ann Clin Psychiatry       Date:  2005 Jul-Sep       Impact factor: 1.567

3.  Understanding the unique characteristics of suicide in China: national psychological autopsy study.

Authors:  Gong-Huan Yang; Michael R Phillips; Mai-Geng Zhou; Li-Jun Wang; Yan-Ping Zhang; Dong Xu
Journal:  Biomed Environ Sci       Date:  2005-12       Impact factor: 3.118

Review 4.  Schizophrenia and suicide: systematic review of risk factors.

Authors:  Keith Hawton; Lesley Sutton; Camilla Haw; Julia Sinclair; Jonathan J Deeks
Journal:  Br J Psychiatry       Date:  2005-07       Impact factor: 9.319

5.  Correlates of suicide attempts and ideation in schizophrenia.

Authors:  J Landmark; Z Z Cernovsky; H Merskey
Journal:  Br J Psychiatry       Date:  1987-07       Impact factor: 9.319

6.  Suicidality in first episode psychosis is associated with insight and negative beliefs about psychosis.

Authors:  Elizabeth A Barrett; Kjetil Sundet; Ann Faerden; Ingrid Agartz; Unni Bratlien; Kristin Lie Romm; Erlend Mork; Jan Ivar Rossberg; Nils Eiel Steen; Ole A Andreassen; Ingrid Melle
Journal:  Schizophr Res       Date:  2010-08-03       Impact factor: 4.939

7.  Case-control study of the relationship of depressive symptoms to suicide in a community-based sample of individuals with schizophrenia in China.

Authors:  John Kasckow; Nancy Liu; Gretchen L Haas; Michael R Phillips
Journal:  Schizophr Res       Date:  2010-03-12       Impact factor: 4.939

8.  Suicide and the unique prevalence pattern of schizophrenia in mainland China: a retrospective observational study.

Authors:  Michael R Phillips; Gonghuan Yang; Shuran Li; Yue Li
Journal:  Lancet       Date:  2004 Sep 18-24       Impact factor: 79.321

9.  Persistent suicide risk in clinically improved schizophrenia patients: challenge of the suicidal dimension.

Authors:  Amresh Shrivastava; Megan E Johnston; Nilesh Shah; Marco Innamorati; Larry Stitt; Meghana Thakar; David Lester; Maurizio Pompili
Journal:  Neuropsychiatr Dis Treat       Date:  2010-10-05       Impact factor: 2.570

10.  Suicidality in middle aged and older patients with schizophrenia and depressive symptoms: relationship to functioning and Quality of Life.

Authors:  J Kasckow; L Montross; S Golshan; S Mohamed; T Patterson; E Sollanzano; S Zisook
Journal:  Int J Geriatr Psychiatry       Date:  2007-12       Impact factor: 3.485

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.